In biomedicine,tissue engineering only has a little role, delivering extra bladders, tiny arteries, or skin grafts as needed. Even a complete trachea has been transplanted and grown. However, the use of tissue engineering is still in its infancy and is quite expensive. Although scientists have successfully produced livers, lungs, and hearts in the laboratory, they are still a long way from being prepared to implant lab-made organs into humans.
There is a lot of potential and promise in tissue engineering . According to estimates, this market will increase significantly from its current size of $7 billion in 2016 to $17 billion by 2023. A decrease in the quantity of medications a patient requires the ability to produce results that are superior to those of conventional therapies,the elimination of organ rejection because new organs are grown using the patient's own cells,the elimination of organ donation altogether; the reduction of the risk of complications after organ transplantation, the need for fewer follow-up appointments, which lessens the burden on the healthcare system.
Why to Attend:
The Biomed&Tissue Engineering 2023 conference brings together attendees, top researchers, academics, scientists, professors, and representatives of other relevant industries to discuss tissue engineering and regenerative medicine-related topics. To gain an advantage, be the first to publicly announce your examination, advancement, and brand. Meet your target audience and explain your product and services to them. to construct a brand, meet experts, learn in a new environment, gain certification, utilise new strategies, and network internationally.
Biomed&Tissue Engineering 2023 offers the opportunity to interact with eminent scientists, academics, business leaders, and subject matter experts from all over the world.Biomed&Tissue engineering 2023's modest efforts will enable us to make significant advancements in the fields of regenerative medicine and tissue engineering.
Market Analysis:
From 2020 to 2027, the global market for tissue engineering, which was valued at USD 9.9 billion in 2019, is expected to expand at a CAGR of 14.2%. Market growth has been fueled by tissue engineering techniques' capacity to repair irreparable tissue damage. This tendency is also influenced by a surge in the popularity of tissue engineering and regenerative medicine techniques for repairing damaged tissues.
Tissue engineering provides alternatives to surgery, organ transplants, and other mechanical devices in order to repair damaged tissues. Due to changes in lifestyle that have led to an increase in diabetes, obesity, and other ailments, as well as an ageing population, there is an increasing need for effective regeneration treatments.
Associations and Societies:
Biomedical Engineering Society of India
Tissue Engineering and Regenerative Medicine International Society (TERMIS)
Biomedical Engineering SOCIETY
Tissue and Cell Engineering Society
Biomedical Engineering Society of Texas (BEST)
Biomedical Association of Wisconsin (BAW)
Gateway Biomedical Society (GBS)
Georgia Biomedical Instrumentation Society
Colorado Association of Biomedical Equipment Technicians (CABMET)
Washington State Biomedical Association (WSBA)
Virginia Biomedical Association (VBA)
Universities:
Johns Hopkins University (Whiting)
Georgia Institute of Technology
Massachusetts Institute of Technology
stanford University
University of California, Berkeley
University of California--San Diego (Jacobs)
Duke University (Pratt)
University of Pennsylvania
